New vaccine development in //progress with wider protection and global collaboration . SK Bioscience has secured a definitive ...

Intellia's news comes at a challenging time for gene therapies, as multiple serious adverse events and fatalities have been ...

Pfizer Inc. (NYSE: PFE) is navigating a period of strategic upheaval and legal scrutiny as it ends its clinical collaboration ...

He worked with a team at the University of Utah to design the first permanent artificial heart implanted in a human.

He worked with a team at the University of Utah to create a mechanical heart. It was later used in patients awaiting an organ ...

Pfizer Inc. closed 25.65% short of its 52-week high of $31.54, which the company achieved on July 30th.

MRNA technology is already used in Moderna’s and Pfizer/BioNTech’s currently licensed COVID-19 vaccines, which have been found to be safe and effective.

Rep. Mark Green (R-TN) introduced the VITAL Act after a Senate report found Biden health officials downplayed the risk of myocarditis from COVID-19 vaccines.

Choosing dividend stocks is not only about looking at the yield but also ensuring that the company pays regular dividends, ...

The funding was meant to help the U.S. prepare for pandemics triggered by avian flu strains, but now leaves the future of ...

It has been about a month since the last earnings report for Pfizer (PFE). Shares have lost about 5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

The Department of Health and Human Services (HHS) is canceling hundreds of millions of dollars in funding pledged to Moderna to help the company develop, test and license mRNA-based vaccines to ...